These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 729639)

  • 1. Acute and chronic administration of alpha-methyldopa: regional levels of endogenous and alpha-methylated catecholamines in rat brain.
    Conway EL; Louis WJ; Jarrott B
    Eur J Pharmacol; 1978 Dec; 52(3-4):271-80. PubMed ID: 729639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of alpha-methyldopamine in the antihypertensive effect of alpha-methyldopa.
    Waldmeier P; Hedwal PR; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):303-14. PubMed ID: 169487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenaline depletion in the hypothalamus of the rat after chronic alpha-methyldopa.
    Beart PM; Prosser D; Louis WJ
    Clin Exp Pharmacol Physiol; 1981 Jan; 8(1):25-31. PubMed ID: 7471519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression of behavior and the brain content of alpha-methylnorepinephrine and alpha-methyldopamine following the administration of alpha-methyldopa.
    Dominic JA; Moore KE
    Neuropharmacology; 1971 Jan; 10(1):33-44. PubMed ID: 5569305
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between fall in blood pressure and in vivo amine release after alpha-methylDOPA.
    Kapoor V; Chalmers J
    Eur J Pharmacol; 1989 May; 164(3):531-8. PubMed ID: 2767124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alpha-methyldopa on dopamine synthesis and release in rat striatum in vitro.
    Uretsky NJ; Chase GJ; Lorenzo AV
    J Pharmacol Exp Ther; 1975 Apr; 193(1):73-87. PubMed ID: 237116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite changes in turnover of noradrenaline and dopamine in the CNS of ethanol-dependent mice.
    Eisenhofer G; Szabo G; Hoffman PL
    Neuropharmacology; 1990 Jan; 29(1):37-45. PubMed ID: 2304614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of alpha-methyldopa, alpha-methylnorepinephrine, and octopamine on rat arteriolar, arterial, and terminal vascular smooth.
    Altura BM
    Circ Res; 1975 Jun; 36(6 Suppl 1):233-40. PubMed ID: 1093755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alpha-methyldopa on the metabolism of dopamine in the striatum of the rat.
    Uretsky NJ
    J Pharmacol Exp Ther; 1974 May; 189(2):359-69. PubMed ID: 4829219
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha-methyladrenaline: a possible active metabolite of alpha-methyldopa in the rat brain.
    Himeno A; Kunisada K; Niwa M; Ozaki M
    Jpn J Pharmacol; 1985 Sep; 39(1):91-8. PubMed ID: 4068393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure and noradrenaline levels after treatment with alpha-methyldopa, alpha-methyldopamine and alpha-methyl-m-tyrosine.
    Henning M
    J Pharm Pharmacol; 1967 Nov; 19(11):775-9. PubMed ID: 4383705
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of methyldopa metabolites on amine transmitters and adrenergic receptors in rat brain.
    Louis WJ; Conway E; Summers R; Beart P; Jarrott B
    Hypertension; 1984; 6(5 Pt 2):II40-4. PubMed ID: 6094348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous and alpha-methylated catecholamine levels in anterior hypothalamic-preoptic and medullary nuclei in rat brain after chronic alpha-methyldopa administration.
    Conway EL; Louis WJ; Jarrott B
    Neuropharmacology; 1979 Mar; 18(3):287-90. PubMed ID: 440536
    [No Abstract]   [Full Text] [Related]  

  • 14. SOME OBSERVATIONS ON THE PHARMACOLOGY OF ALPHA-METHYLDOPA.
    DAY MD; RAND MJ
    Br J Pharmacol Chemother; 1964 Feb; 22(1):72-86. PubMed ID: 14126060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of forebrain noradrenaline innervation to the central circulatory effects of alpha-methyldopa and 6-hydroxydopamine.
    van den Buuse M; Head GA; Korner PI
    Brain Res; 1991 Feb; 541(2):300-8. PubMed ID: 1905177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of alpha-methyl amino-acids and their derivatives on isolated tissue preparations.
    Gulati OD; Parikh HM; Ringe SY; Sherlekar ML
    Br J Pharmacol; 1970 Dec; 40(4):689-701. PubMed ID: 5495174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after alpha-methyl-p-tyrosine; time- and dose-response relationships.
    Widerlöv E; Lewander T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):111-23. PubMed ID: 703854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyldopa abolishes neurally evoked contractions of the vas deferens in vitro.
    Tayo FM
    Arch Int Pharmacodyn Ther; 1979 Apr; 238(2):187-95. PubMed ID: 475507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAILURE OF RESERPINE TO DEPLETE NORADRENALINE NEURONS OF ALPHA-METHYLNORADRENALINE FORMED FROM ALPHA-METHYL DOPA.
    CARLSSON A; DAHLSTROEM A; FUXE K; HILLARP NA
    Acta Pharmacol Toxicol (Copenh); 1965; 22():270-6. PubMed ID: 14328199
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavior and brain contents of catecholamines in mice during chronic administration of methyldopa.
    Dominic JA; Moore KE
    Neuropharmacology; 1971 Sep; 10(5):565-70. PubMed ID: 4399541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.